BDNF and Parkinson disease: Accordingly, augmenting BDNF is a promising therapeutic strategy in Parkinson’s disease, not only by protecting from dopaminergic neuronal degeneration but also via augmenting dopaminergic transmission, as supported by preclinical and clinical evidence [198].